Metraipolis › archive › dc_d27259ed2ffe

Real-world use of ixekizumab for axial spondyloarthritis treatment in Spain (ESPADA study) — Europe PMC PMID:41585216

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41585216
DOI
10.3389/fmed.2025.1704081
License (as archived)
solo-consultazione
Archived
2026-11-06T22:37:25.707Z
SHA-256 of the archived text
3a0d7af32b4fc45fa97387c0a1f5eb5041dab50fce66cead627af02acf13c809
Stable URL of this page
https://metraipolis.com/documento/dc_d27259ed2ffe

How to cite

Real-world use of ixekizumab for axial spondyloarthritis treatment in Spain (ESPADA study) — Europe PMC PMID:41585216 — Europe PMC (en), https://europepmc.org/article/MED/41585216 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d27259ed2ffe (Metraipolis archive dc_d27259ed2ffe, sha256 3a0d7af32b4fc45fa97387c0a1f5eb5041dab50fce66cead627af02acf13c809)
BibTeX
@misc{dcd27259ed2ffe,
  title = {Real-world use of ixekizumab for axial spondyloarthritis treatment in Spain (ESPADA study) — Europe PMC PMID:41585216},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41585216},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d27259ed2ffe; sha256 3a0d7af32b4fc45fa97387c0a1f5eb5041dab50fce66cead627af02acf13c809},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41585216. Agents can read the archived copy with the MCP tool read_document.